Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Personalised medicine and nursing

Paula Reiger – Oncology Nursing Society, USA
Personalised medicine and nursing ( Paula Reiger – Oncology Nursing Society, USA )
11 May 2012

Oncology nurses should take the lead

Birgitte Grube - President of EONS
Oncology nurses should take the lead ( Birgitte Grube - President of EONS )
10 May 2012

Communication in genetics and genomics

Anne-Elizabeth Murphy - Hôpitaux Universitaires de Genève, Switzerland
Communication in genetics and genomics ( Anne-Elizabeth Murphy - Hôpitaux Universitaires de Genève, Switzerland )
9 May 2012

Targeted therapy for refractory Ewing’s Sarcoma tumours

Dr Aung Naing -University of Texas MD Anderson Cancer Center, Houston, USA
Targeted therapy for refractory Ewing’s Sarcoma tumours ( Dr Aung Naing -University of Texas MD Anderson Cancer Center, Houston, USA )
13 Apr 2012

Mouse models of metastatic breast cancer

Prof Jos Jonkers - Netherlands Cancer Institute, Amsterdam
Mouse models of metastatic breast cancer ( Prof Jos Jonkers - Netherlands Cancer Institute, Amsterdam )
4 Apr 2012

Analysis of thirty years of clinical trial data

Prof Richard Peto - Clinical Trial Service Unit, Oxford University, UK
Analysis of thirty years of clinical trial data ( Prof Richard Peto - Clinical Trial Service Unit, Oxford University, UK )
23 Mar 2012

Recent advances in multiple myeloma therapy

Prof San Miguel, Prof Philippe Moreau, Prof Antonio Palumbo, Prof Meletios Dimopoulos and Prof Thierry Facon
Recent advances in multiple myeloma therapy ( Prof San Miguel, Prof Philippe Moreau, Prof Antonio Palumbo, Prof Meletios Dimopoulos and Prof Thierry Facon )
14 Feb 2012

Recent advances in non-Hodgkin’s lymphoma therapy

Prof Mathias Rummel, Prof Umberto Vitolo, Prof Georg Hess, Prof Finbarr Cotter
Recent advances in non-Hodgkin’s lymphoma therapy ( Prof Mathias Rummel, Prof Umberto Vitolo, Prof Georg Hess, Prof Finbarr Cotter )
14 Feb 2012

BTK inhibitor PCI-32765 induces durable responses in relapsed or refractory chronic lymphocytic leukaemia/small lymphocytic lymphoma

Prof Susan O’Brien - University of Texas MD Anderson Cancer Center, Houston
BTK inhibitor PCI-32765 induces durable responses in relapsed or refractory chronic lymphocytic leukaemia/small lymphocytic lymphoma ( Prof Susan O’Brien - University of Texas MD Anderson Cancer Center, Houston )
9 Jan 2012

Obinutuzumab with rituximab in patients with relapsed CD20 and indolent B-Cell non-hodgkin lymphoma (GAUSS)

Dr Laurie Sehn - University of British Columbia, Vancouver, Canada
Obinutuzumab with rituximab in patients with relapsed CD20 and indolent B-Cell non-hodgkin lymphoma (GAUSS) ( Dr Laurie Sehn - University of British Columbia, Vancouver, Canada )
9 Jan 2012

Clinical trial data on treatment of chronic lymphocytic leukaemia with PCI-32765

Dr Susan O’Brien – MD Anderson Cancer Center, Houston, USA
Clinical trial data on treatment of chronic lymphocytic leukaemia with PCI-32765  ( Dr Susan O’Brien – MD Anderson Cancer Center, Houston, USA )
19 Dec 2011

New data on aggressive B cell lymphoma

Dr Elaine Jaffe – National Cancer Institute, Bethesda, USA
New data on aggressive B cell lymphoma ( Dr Elaine Jaffe – National Cancer Institute, Bethesda, USA )
19 Dec 2011